Public signalCompany raiseAuto-indexed · Unverified
Alveus Therapeutics, Inc. raised $56.9M
Alveus Therapeutics, Inc.· PHILADELPHIA, US· Pharmaceuticals· Filed Jan 14, 2026
Alveus Therapeutics, Inc. reported raising capital. Based in PHILADELPHIA, PENNSYLVANIA, US. First sale reported 2025-12-22. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$56.9M
Confidence90%
Raised
$56.9M
Investors
17
Incorporated
2023
Jurisdiction
DELAWARE
On the record
- Location
- PHILADELPHIA, US
- Sector
- Pharmaceuticals
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $56.9M
- Target amount
- $110.7M
- Filing date
- Jan 14, 2026
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- DELAWARE
- Year incorporated
- 2023
- Industry group
- Pharmaceuticals
- Number of investors
- 17
- Includes non-accredited investors
- No
- Revenue range
- Decline to Disclose
- Total offering amount
- $110.7M
- Amendment
- No
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Ameet Nathwani
Director
Philadelphia, US
Carlo de Notaristefani
Director
Philadelphia, US
Claudio Nessi
Director
Philadelphia, US
Garrett Ingram
Director
Philadelphia, US
Gregory Parekh
Director
Philadelphia, US
Ivan Gergel
Director
Philadelphia, US
Jan Van de Bossche
Director
Philadelphia, US
Raj Kannan
Executive Officer
Philadelphia, US
Sources & provenance
“Operating company sold 56,862,480 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Jan 14, 2026. Details beyond the filing have not been verified.
Tags
USCompanyPharmaceuticals$10M – $100MCompany Raise
Are you associated with Alveus Therapeutics, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record